Anxious and Depressive Disorders and Their Comorbidity: Effect on Central Nervous System Noradrenergic Function
dc.contributor.author | Cameron, Oliver G. | |
dc.contributor.author | Abelson, James L. | |
dc.contributor.author | Young, Elizabeth A. | |
dc.date.accessioned | 2007-05-15T17:37:23Z | |
dc.date.available | 2007-05-15T17:37:23Z | |
dc.date.issued | 2004-12-01 | |
dc.identifier.citation | BIOL PSYCHIATRY 2004;56:875–883 <http://hdl.handle.net/2027.42/51379> | en |
dc.identifier.uri | https://hdl.handle.net/2027.42/51379 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=15576065&dopt=citation | en_US |
dc.description.abstract | Background: Although comorbidity of anxiety with depression is common, investigations of physiologic abnormalities related specifically to comorbidity are rare. This study examined relationships of DSM-IV-defined depression, anxiety, and their comorbidity to noradrenergic function measured by blunting of the growth hormone (GH) response to the alpha2 adrenoreceptor agonist (and imidazoline receptor agent) clonidine and by blood pressure and symptom responses. Methods: Fifteen subjects with pure social anxiety or panic disorder, 15 with pure major depression, and 18 with both depression and anxiety were compared with healthy control subjects matched for age and gender. Other factors known to affect GH (weight, menstrual status, prior antidepressant, or other drug exposure) were controlled. Results: Anxiety produced GH blunting, but depression was associated with normal GH responses. The comorbid state did not affect results beyond the impact of anxiety. Preclonidine stress-related GH elevations were observed, to the greatest degree in anxious subjects. Relevant symptom, but not blood pressure, changes were significantly associated with blunting. Conclusions: With use of pure depression and anxiety groups and careful control of other factors known to affect GH, these results demonstrate central nervous system noradrenergic dysfunction in anxiety disorders. In contrast to less rigorously controlled studies, noradrenergic function in depression was normal. | en |
dc.description.sponsorship | NIMH Grant No. MH57751 (all authors), MH01931 (EAY), and MO1 RR00042 (University of Michigan General Clinical Research Center). | en |
dc.format.extent | 361499 bytes | |
dc.format.mimetype | application/pdf | |
dc.language.iso | en_US | en |
dc.publisher | Elsevier | en |
dc.subject | Clonidine | en |
dc.subject | Growth Hormone | en |
dc.subject | Depression | en |
dc.subject | Anxiety | en |
dc.title | Anxious and Depressive Disorders and Their Comorbidity: Effect on Central Nervous System Noradrenergic Function | en |
dc.type | Article | en |
dc.subject.hlbsecondlevel | Molecular, Cellular and Developmental Biology | |
dc.subject.hlbsecondlevel | Neurosciences | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.description.peerreviewed | Peer Reviewed | en |
dc.contributor.affiliationum | Psychiatry | en |
dc.contributor.affiliationum | MBNI | en |
dc.contributor.affiliationumcampus | Ann Arbor | en |
dc.identifier.pmid | 15576065 | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/51379/1/CameronGH.pdf | en_US |
dc.identifier.source | Biological Psychiatry | en_US |
dc.owningcollname | Molecular and Behavioral Neurosciences Institute |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.